Topical retinoids for acne

THERAPEUTIC APPROACH TO ACNE AND ROSACEA

Topical retinoids for acne

Jun
2016
Vol. 35. No. 2
Lauren Meshkov Bonati, MD | Lindsey Yeh, MD | Nanette B Silverberg, MD

Topical retinoids are currently approved by the US Food and Drug Administration for the treatment of acne vulgaris in nonpregnant, nonlactating patients 12 years of age and older. Their efficacy, safety, and tolerability are well documented for inflammatory and noninflammatory acne with studies repeatedly demonstrating a decrease in the number of lesions, significant improvement in acne severity, improvement in the cosmetic appearance of acne, and the prevention of acne lesions through microcomedone formation. There is some variability between prescription retinoid products regarding efficacy, safety, and tolerability; with erythema, peeling, and dryness being common, potential side effects. Due to their efficacious and safe profile, topical retinoids remain the first-line treatment for acne vulgaris.

Semin Cutan Med Surg 35:50-56 © 2016 Frontline Medical Communications

PURCHASE NOW